Abstract The nmf193 mutant was generated by a largescale ENU mutagenesis screen and originally described as having a dominantly inherited phenotype characterized by fundus abnormalities. We determined that nmf193 mice exhibit outer-segment defects and progressive retinal degeneration. Clinical examination revealed retinal spotting apparent at 6 weeks of age. Histologic analysis of homozygous mutant mice at 6 weeks indicated an absence of outer segments (OS) and a 50% reduction of photoreceptor cells which progressed to complete loss of photoreceptors by 10 months. Mice heterozygous for the nmf193 mutation had a less severe phenotype of shortened outer segments at 2 months with progressive loss of photoreceptor cells to 50% by 10 months. A positional cloning approach using a DNA pooling strategy was performed to identify the causative mutation in nmf193 mice. The nmf193 mutation was linked to chromosome 17 and fine mapped to an interval containing the peripherin/rds (Prph2) gene. Mutation analysis identified a single base change in Prph2 that causes aberrant splicing between exons 1 and 2. Interestingly, a comparative histologic analysis demonstrated that Prph2 nmf193/? mutants have similar photoreceptor degeneration to that of Nr2e3 rd7/rd7 . We show that Prph2 mRNA and protein levels are reduced in the Nr2e3 rd7/rd7 mutant compared to control littermates. Chromatin immunoprecipitation analysis shows that Prph2 is a direct target of NR2E3. In addition, the downregulation of Prph2 gene expression is similar in both the Nr2e3 rd7/rd7
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Introduction
ENU mutagenesis screens in model organisms have yielded a wealth of information on gene function with particular relevance to disease. Several groups have performed largescale mutagenesis screens using the mouse (Clark et al. 2004) , including those focused on generating novel models of retinal disease (Baird et al. 2002; Jablonski et al. 2005; Pinto et al. 2004 ). The main advantage of this phenotypedriven approach is that mutagenesis is random, thus allowing for the generation of an allelic series of mutations as well as mutations in genes that currently have no functional information or disease association (Justice et al. 1999) . Allelic mutations, such as the one described in this study, provide valuable insight into protein function. Furthermore, it becomes possible to generate a large number of unique single-gene mutants with a particular phenotype, such as progressive retinal degeneration, and identify the causative mutations. The identification of these mutations associated with a group of mutants with similar phenotypic manifestations ultimately provides a more complete understanding of pathologic mechanisms that may be shared between genetically distinct diseases.
In this study we aimed to identify the causative mutation in the novel mouse mutant nmf193. This mutant was originally described by the Neuroscience Mutagenesis Facility at the Jackson Laboratory as a dominant phenotype characterized by an abnormal fundus appearance by 8 weeks of age. We show that this phenotype is semidominant and has a slow progressive degeneration of the retina. We report the genetic mapping of nmf193 and identification of a causative mutation in the peripherin/rds (Prph2) gene. PRPH2 is a tetraspanin protein that localizes to the rims of the disc membranes (Travis et al. 1991) . Prph2 is involved in the formation of outer segments and the maintenance of their morphology (Loewen et al. 2001; Wrigley et al. 2000) . In addition, Prph2 has been reported to promote fusion of opposing disc membranes in vitro (Boesze-Battaglia et al. 1998) .
Prph2 was identified as the gene mutated in the retinal degeneration slow (rds) mutant (Connell et al. 1991; Travis et al. 1989) . While the original rds mutant is due to an insertion that causes a null allele (Ma et al. 1995) , subsequent mouse transgenic models have demonstrated that both dominant negative and haploinsufficient alleles cause disease, depending on the mutation that the transgene carries. Transgenic animals carrying common human mutations, R172 W or P216L, exhibit reduced function of the photoreceptor on a wild-type background, which indicates a dominant negative effect of the allele (Ding et al. 2004; Kedzierski et al. 1997) . The del307 mutation has a similar dominant negative effect, having a more severe phenotype than the null allele alone (McNally et al. 2002) . In contrast, the C214S transgenic mutation does not affect the retina on a wild-type background or heterozygous mutant background, indicating that the mutation is a loss-of-function allele . This is partly explained by the differential intracellular localization of allelic variants in the photoreceptor. The loss-of-function allele C214S is not transported to the outer segment, while the dominant negative allele P216L forms a tetramer and is transported to the outer segment (Loewen et al. 2003) , thereby allowing the mutant allele to interfere in the structural organization of the outer segments. Several mutations in human Prph2 have been associated with autosomal dominant retinitis pigmentosa (Farrar et al. 1991; Keen and Inglehearn 1996) and various patterned macular dystrophies (Felbor et al. 1997; Kim et al. 1995; Nichols et al. 1993; Wells et al. 1993 ). Significant variation of the disease is seen with different mutations (Kohl et al. 1998) , and also within a family segregating the same mutation (Weleber et al. 1993) , suggesting the existence of genetic modifiers.
In the nmf193 mutant, the haploinsufficiency of Prph2 causes a slow progressive degeneration of the photoreceptors, grossly similar to that of the Nr2e3 rd7/rd7 mutant (Akhmedov et al. 2000; Haider et al. 2001) . The Nr2e3 rd7/rd7 mouse has a developmental phenotype characterized by an excess of blue cone cells and whorls and rosettes in the retina caused by a mutation in the transcription factor NR2E3. Nr2e3 rd7/rd7 mice also exhibit a delay in the formation of outer segments (Haider et al. 2006) ; when outer segments do form they are shortened, similar to the haploinsufficient Prph2 nmf193/? mouse. NR2E3 is involved in the regulation of several genes Cheng et al. 2004; Corbo and Cepko 2005) . Since reduced levels of Prph2 are sufficient for photoreceptor loss, if a mutation in Nr2e3 either directly or indirectly reduced Prph2 levels, then it would be expected to cause degeneration over a similar time course. In this study we show that Prph2 is downregulated in Nr2e3 rd7/rd7 mutants at the mRNA and protein level at a postnatal time point prior to the onset of degeneration and after the morphogenesis of the outer segments should be complete. Furthermore, chromatin immunoprecipitation data show that NR2E3 binds to a recognition site upstream of Prph2. These data suggest that Prph2 is involved in the pathology of Nr2e3 rd7/rd7 , which is supportive of a common degenerative pathway.
Experimental methods

Animal husbandry
All animals were bred and maintained under standard conditions at the UNMC research vivarium in accordance with IACUC standards. A mating cross of CAST/EiJ 9 C57BL6/ J nmf193/? was established to generate F1 offspring. Affected offspring were backcrossed to CAST/EiJ to generate progeny for mapping. Mice were maintained under constant environmental conditions to ensure the disease course progressed naturally. Tissues were harvested from B6.CgNr2e3 rd7/rd7 , C57BL/6 J (B6), Prph2 nmf193/? , and Prph2 nmf193/nmf193 at 6 weeks, 3 months, 6 months, and 10 months. A minimum of three mice were analyzed for each time point. Mice were genotyped for the Nr2e3 rd7/rd7 mutation as previously described (Haider et al. 2001 ).
Fundus photography
Pupils were dilated with 1% atropine sulfate (Alcon, Forth Worth, TX) in a dark room. Fundus images were captured on a Kowa Genesis digital fundus camera (Kowa Company Ltd., Japan). A 90-mm diopter lens (Volk, Mentor, OH) was held in place under the camera lens so that it filled the field of view (Hawes et al. 1999) . Obligate wild-type, heterozygous, and homozygous mutant mice were imaged at 1.5, 3, and 9 months; n [ 3 for each genotype and age. Adult Nr2e3 rd7/rd7 mice were phenotyped by indirect ophthalmoscopy for the characteristic panretinal spots prior to additional analysis.
Electroretinography (ERG)
ERG analysis was performed on wild-type, heterozygous, and homozygous mutant mice at 2 and 10 months. Mice were dark-adapted overnight and anesthetized with an intraperitoneal injection of normal saline solution containing ketamine (15 mg/g) and xylazine (7 mg/g body weight). ERG recordings were performed using the UTAS E4000 system (LKC Technologies Inc., Gaithersburg, MD). Pupils were dilated with 1% atropine sulfate and a silver-coated nylon thread electrode was placed at the corneal surface of one eye for recording. A needle electrode placed under the skin of the forehead served as ground. A drop of 1% sodium carboxymethylcellulose was placed on the corneal surface in conjugation with a contact lens to ensure electrical contact and to maintain corneal integrity. Body temperature was maintained at a constant temperature of 38°C using a Themipaq heating pad. All stimuli were presented in a Ganzfeld chamber/light emitter (LKC Technologies, Gaithersburg, MD) whose interior surface was painted with a highly reflective white matte paint (No. 6080; Eastman Kodak, Rochester, NY). Stimuli were generated with a Sunburst UTAS Visual Diagnostic system (LKC Technologies). Dark-adapted responses were recorded to shortwavelength (k max = 470 nm; Wratten 47A filter) flashes of light over a 4.0 log unit range of intensities (0.3 log unit steps) up to the maximum allowable by the photic stimulator. Lightadapted responses were obtained with white flashes (0.3 step) on a rod-saturated background after 10 min of exposure to the background light to allow complete light adaptation. Responses were amplified with an UBA-4200 series Universal DC Biomedical Amplifier (LKC Technologies) and digitized using an I/O board (model PCI-1200; National Instruments, Austin, TX) in a personal computer. Signal processing was performed with EM for Windows version 7.1.2. Signals were sampled every 0.8 ms over a response window of 200 ms. For each stimulus condition, responses were computer averaged, with up to 50 records for the weakest signals. A signal rejection window could be adjusted during data collection to eliminate electrical artifacts.
Histologic analysis
Eyes were collected from wild-type, homozygote, and heterozygote mutants at 1.5, 6, and 10 months (n [ 3 per sample and age). Tissues were marked with a cautery prior to enucleation to designate dorsal ventral orientation. Tissue was collected from age-matched littermates and eyes were fixed in 3:1 methanol:acetic acid or 4% paraformaldehyde solution overnight, embedded in paraffin, and sectioned at 5 lm. Sections covering an area of 200 lm, approximately 100 lm dorsal to the optic nerve head, were collected on vectabond-coated slides. Hematoxylin and eosin staining and TUNEL analysis was performed as before (Haider et al. 2001 (Haider et al. , 2006 . TUNEL-positive cells were counted across the retina on sections totaling 100 lm from the central retina in three mice from each mutant. Sections were visualized on a Ziess AxioPlan 2 (Carl Ziess MicroImaging, Inc., Thornwood, NY) and imaged with an AxioCam C using Axiovision 4.3 software. Counts of existing photoreceptor nuclei were made at 10 months in Nr2e3 rd7/rd7
, Prph2 nmf193/? , and control retinas (n = 3) from hematoxylin and eosin-stained sections. Two 50-lm fields were counted 400 lm on either side of the optic nerve head. The average number of photoreceptor nuclei were compared to wild-type to determine the percentage of lost photoreceptors.
Genetic mapping DNA was isolated from tail tips excised from 2-week-old pups. Genotyping for linkage analysis was performed using a screening set of 67 STRP markers. Equimolar amounts of DNA from seven unaffected and ten affected mice were pooled in two separate tubes. DNA was amplified by PCR using the following conditions: 40 ng DNA in an 10-ll PCR reaction mixture containing 1.25 ll PCR buffer (100 mM Tris-HCl [pH 8.8], 500 mM KCl, 15 mM MgCl 2 , and 0.01% w/v gelatin); 200 mM each dATP, dCTP, dGTP, and dTTP; 2.5 pmol of each forward and reverse primer; and 0.25 U Taq polymerase. Reaction mixtures were subjected to 40 cycles of 94°C for 30 sec, 55°C for 30 sec, and 72°C for 30 sec. Products were electrophoresed on a 4% agarose gel containing ethidium bromide and visualized by UV transillumination.
Mutation analysis
Mutation analysis was performed by directly sequencing genomic DNA using primers that were designed flanking the exons of Prph2. DNA was amplified as above. RT-PCR was performed using primers specific to the Prph2 mRNA using the Titan-one RT-PCR kit (Roche, Basel, Switzerland) per the manufacturer's instructions. RNA was isolated from mutant and wild-type retinas as before (Haider et al. 2006) . The appropriate bands were excised and DNA was recovered using the Qiagen Gel Extraction kit (Qiagen Inc., Valencia, CA) per the manufacturer's instructions. Purified PCR and RT-PCR products were sequenced by the DNA Sequencing Core at UNMC. Nucleotide and amino acid sequences were analyzed using Sequencher 4.6 (Gene Codes Corp., Ann Arbor, MI).
Western blot analysis
Western blot analysis was performed using 20 lg of protein per sample as before ). Briefly, control, Prph2 nmf193/? , Prph2 nmf193/nmf193 mutant retinas were dissected from 1.5-month-old mice and lysed in RIPA buffer (1 9 Tris-buffered saline [TBS], 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 0.04% sodium azide, 1 mM PMSF). Samples were electrophoresed on 4-12% Tris-Bis NuPage gels (Invitrogen Corp., Carlsbad, CA). Proteins were transferred onto PVDF membranes and Western blot analysis was performed using the Odyssey Infrared Imaging System (LiCOR Biosciences, Lincoln, NE) according to the manufacturer's recommendations. Blots were incubated in Odyssey blocking solution for 1 h at room temperature. Primary antibody:anti-PRPH2 at 1:1000 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) or anti-b-actin at 1:1000 (Santa Cruz Biotechnology) was incubated in Odyssey blocking solution overnight at 4°C, then washed in PBS. A secondary antibody, anti-goat IgG, was incubated at 1:20,000 for 1 h on the blot at room temperature, and the blot was washed in PBS (AlexaFluor680, Invitrogen Corp.). Images were detected with the Odyssey system using the proper infrared channels and visualized using Odyssey v1.2 software.
Expression analysis
Real-time RT-PCR was used to determine relative expression levels of Prph2 in Prph2 nmf193/? , Prph2 nmf193/nmf193 , and control retinas as previously described (Haider et al. 2006) . Total RNA was isolated from retinas of P14 (n = 3) mice. Primers spanning exons 1 and 2 of Prph2 were selected to amplify the wild-type message only (F, 5 0 -AGGT CAAAGATCGCATCAAG-3 0 and R, 5 0 -CTGTAGTA ATTCAGCAGAGC-3 0 ) and total message, wild-type, and mutant (F, 5 0 -TCCCTCCCACAAAGCACTATG-3 0 and R, 5 0 -TGGTCTCAGATGGCCACAAC-3 0 ). Reaction products were diluted 1:100 and 1 ll was used as template for amplification using the following 10-ll reaction mixture: 100 pmol each forward and reverse primer and 5 ll SYBR Green PCR master mix (Applied Biosystems, Foster City, CA). PCR was carried out on an ABI 7500 using the manufacturer's recommended cycling parameters. Biological and technical triplicate reactions were performed. Expression of Prph2 was normalized to that of b-actin. Significance was calculated using Student's t test. Comparisons between mutant and wild-type controls were made for fold change estimation and relative expression using the following formula: 1000/2 DCtbactin-DCttestgene . For comparison of Prph2 message level between Nr2e3 rd7/rd7 and wild-type controls, the above protocol was repeated with P21 retinas (n = 7).
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed using reagents from the ChIP kit (Upstate, Millipore) and a modified protocol. Briefly, retinas were dissected from P2 or P21 C57BL/6 J eyes (8-10 eyes per ChIP; three independent assays per time point) and placed into 400 ll PI buffer 1 tablet protease inhibitor cocktail, (Roche in 10 ml PBS) on ice. Chilled retinas were dissociated and crosslinked in 37% formaldehyde (1% final concentration) for 20 min at room temperature on a rotating platform. One molar glycine was added to achieve a final concentration of 0.125 mM and retinas were incubated for an additional 5 min and rinsed twice with PI buffer before lysis. Retinas were lysed on ice and sonicated on ice using a Misonix Sonicator 3000 (power 5, pulse 10 9 , 30-sec pause between pulses; 150 total pulses). Retina lysates were precleared using a salmon sperm DNA/protein A Agarose-50% slurry, and immunoprecipitation was performed overnight with approximately 1 lg NR2E3 antibody (Haider et al. 2006 ) at 4°C with rotation. Immunoprecipitated samples were eluted with 1% SDS and 0.1 M NaHCO 3 buffer, and reverse crosslinked with NaCl (200 mM final concentration) and incubated with 10 mg RNAse A at 65°C for 5 h. Input (control) samples were isolated similarly and incubated with preclear solution instead of antibody or with goat IgG antibody (negative control). PCR reactions were performed using 1 ll of 1:10 diluted Input or Experimental (NR2E3 precipitated) sample under standard PCR conditions as previously described (Haider et al. 2001 ) using an annealing temperature of 58°C and 35 cycles. PCR reactions were electrophoresed in a 2% agarose gel and visualized by ethidium bromide staining. Forward (GCTACACACTTCCTTGTTAAG) and reverse (CTGACCTGCTAGCACTTTGTTC) primers were chosen approximately 100 nucleotides 5 0 and 3 0 , respectively, from a putative response element sequence to amplify approximately 200-bp products.
Immunohistochemistry
Immunohistochemical analysis was performed on 6-lm serial sections of B6 and Nr2e3 rd7/rd7 eyes. Paraffinembedded eyes were fixed with either 4% PFA, methanol/ acetic acid (3:1), or Z-fix (Anatech Ltd.) and maintained at a dorsal/ventral orientation. Frozen sections were prepared from eyes enucleated and immediately placed in 30% sucrose overnight, followed by immersion in a 50:50 mixture of 30% sucrose and OCT for 8-12 h. Specimens were subsequently embedded in OCT and sectioned on a cryostat. After blocking with 2% normal goat or horse serum (Vector Laboratories, Burlingame, CA) in PBS, sections were incubated with primary PRPH2 antibody (goat, 1:200, Santa Cruz Biotechnology) at 4°C overnight. The next day, samples were rinsed and incubated in secondary antibody (anti-goat 488 AlexaFluor antibody by Molecular Probes, Invitrogen, Carlsbad, CA). Images from sections were collected on a Zeiss Axioplan II fluorescent microscope equipped with the appropriate bandpass filters for each fluorochrome.
Results
Nmf193 maps to chromosome 17
A mapping cross was generated by backcrossing affected offspring from a C57BL6/J nmf193/? 9 CAST/EiJ cross to CAST/EiJ. Linkage was identified using a genome-wide screen on pooled DNA samples. A single marker, D17Mit200, was identified as homozygous for the CAST/EiJ allele in the unaffected pool (Fig. 1a, b) . Individual DNA samples were genotyped with this marker and additional flanking markers. Linkage was observed with D17Mit200 and D17Mit28, while flanking markers D17Mit46 and D17Mit86 had recombinant animals (Fig. 1c) . This narrowed the disease interval to approximately 19 cM. This region is relatively large; however, upon examination of the genes within the interval, a strong candidate gene, Prph2, was found near the linked marker D17Mit200.
A point mutation causing aberrant splicing of Prph2 mRNA results in the nmf193 retinal degeneration The Prph2 gene was screened for mutations by directly sequencing PCR products. Genomic DNA fragments were PCR amplified using primers flanking exons to amplify the coding region and splice sites of the gene. No coding region mutations were identified; however, a T-to-A mutation was identified in the invariant T of the exon 1 splice donor (Fig. 2) . The Prph2 mRNA was amplified by RT-PCR. In the RNA from the mutant retina an aberrantsized transcript was identified, indicating the use of an inappropriate downstream splice donor (Fig. 3a) . Furthermore, using primers that were designed to span the exon 1 and exon 2 junction, and therefore amplify only wild-type message, a 2.8-fold reduction in the level of Prph2 mRNA was detected by quantitative RT-PCR from Prph2 193/? mutants (Fig. 3b) . In the homozygous mutants no wild-type message was detected and mutant message was present, but at 2.9-fold lower levels. The mutant and wild-type products were sequenced and the same T-to-A splice site mutation was identified in mutant transcripts causing the incorporation of 25 nucleotides (Fig. 2d) . The message then splices to the normal splice acceptor in exon 2 from a cryptic splice donor site. This mutation causes the incorporation of 49 missense amino acids before prematurely terminating the protein. Approximately one half of the tetraspanin domain is altered or missing (Fig. 4a) . Western blot analysis showed that the wild-type protein is present in heterozygotes but absent from homozygotes; a truncated protein is not detected (Fig. 4b) . Consistent with quantitative RT-PCR results, the quantity of wild-type protein is visibly reduced in the heterozygote. To determine the pathophysiology of retinal degeneration in nmf193 mice, we tracked the clinical progression of the disease by indirect ophthalmoscopy. Wild-type, Prph2 nmf193/? , and Prph2 nmf193/nmf193 mice were evaluated for fundus abnormalities at 4-6 weeks, 3 months, and 9 months. Prph2 nmf193/nmf193 mice had severe degeneration characterized by large regions of hypopigmentation apparent at eye opening (data not shown) but progressed to span the majority of the retina by 3 months (Fig. 5b) . In contrast, Prph2 nmf193/? mice showed a progressive deterioration (Fig. 5c-e) . Prph2 nmf193/? did not show fundal abnormalities until 1.5 months of age when a few light retinal spots were observed (Fig. 5c) . Interestingly, 1 week prior, these spots were not observed in the same animal, suggesting a key transition period in the retina at 4-5 weeks. The spots had an increased density at 3 months and attenuated blood vessels were commonly observed by this time (Fig. 5d) . At 9 months the fundus was severely hypopigmented, similar to a 3-month Prph2 nmf193/nmf193 retina, and only remnants of blood vessels could be found (Fig. 5e ).
Outer-segment defects accompany photoreceptor loss in nmf193 mutant mice To determine the morphologic changes associated with the nmf193 mutation, retinal sections from wild-type, Prph2 nmf193/? , and Prph2 nmf193/nmf193 mutants were histologically examined by hematoxylin and eosin staining. Sixweek-old heterozygous mutant mice had a normal retina except that the outer segments were shorter compared to wild-type (Fig. 6) . By 6 months of age, Prph2 nmf193/? mutant mice had an approximately 70% reduction of Fig. 3 The mutation causes a reduction of wild-type messages in mutant animals. Panel (a) RT-PCR of RNA from C57BL/6 J (wt), heterozygous (?/-), and homozygous mutants (-/-). The 25-bp insertion into the message is seen at albeit reduced levels. Panel (b) depicts relative expression of Prph2 using a primer that detects only wild-type message in a quantitative RT-PCR assay. Expression is given as number of molecules per 1000 molecules of b-actin; genotype is indicated on the x axis Fig. 4 The mutation causes a frameshift and a nonsense codon that truncates the protein (a). Shaded areas indicate the region of the protein that is equivalent to wild-type, the red underlined sequence indicates the tetraspanin domain. Western blot analysis (b) shows the reduction of wild-type protein in the heterozygous mutant (?/-) and its absence in the homozygous mutant (-/-). b-actin is shown as a loading control Fig. 5 Abnormal appearance of the nmf193 fundus. Fundus images of heterozygous mutants were taken at 1.5 (c), 3 (d), and 9 months (e). A 3-month-old homozygous mutant (b) and wild-type control are shown for comparison (a) photoreceptor cells (outer nuclear layer, ONL) and many displaced nuclei were observed in the outer segments (OS). At 10 months of age, the ONL was reduced to approximately four cells. Retinal degeneration was more pronounced in Prph2 nmf193/nmf193 mutant mice where the ONL at 1 month was considerably thinner, similar to the 10-month-old Prph2 nmf193/? mutants, with absent outer segments. Further degeneration was seen in Prph2 nmf193/nmf193 mutants at 6 months (ONL was 2 cells thick), and by 10 months essentially no outer nuclear layer or outer segments were observed.
ERG analysis reveals loss of photoreceptor function in nmf193 mutant mice To determine the effect of outer-segment defects and loss of photoreceptor cells on rod and cone photoreceptor function, electroretinogram analyses were performed on Prph2 nmf193/? and Prph2 nmf193/nmf193 mutants and controls at 2 and 10 months of age. Consistent with clinical and histologic observations, Prph2 nmf193/? mutants had progressive loss of rod function and cone function and Prph2 nmf193/nmf193 mutants exhibited a more severe phenotype (Fig. 7) . As observed for other mutants involving Prph2, rod degeneration preceded cone degeneration (Cheng et al. 1997; Farjo et al. 2006) . Prph2 nmf193/? mice showed 68.4% rod function (dark adapted) and 84.6% cone function (light adapted) at 2 months compared to normal. By 10 months, Prph2 nmf193/? mutants had approximately 43.6% of normal rod function and 63.9% of normal cone function. In contrast, Prph2 nmf193/nmf193 mutants showed negligible rod function compared to normal, even at 2 months, while cone function was approximately 31.6% of normal at 2 months. A complete loss of rod and cone function was observed in homozygous mutants by 10 months. and Nr2e3 rd7/rd7 mice have a similar rate of retinal degeneration, 10-month-old Prph2 nmf193/? and Nr2e3 rd7/rd7 mice were histologically compared. A similar reduction in the ONL between Prph2 nmf193/? and Nr2e3 rd7/rd7 mice was observed (Fig. 8a, b) . Remaining photoreceptor nuclei were counted in 50-lm fields, 400 lm on either side of the optic nerve head in both mutants compared to age-matched Heterozygous and homozygous mutants at 2 and 10 months were compared to age-matched wild-type controls. Average b-wave amplitude from mice of each genotype is given as a percentage of wild-type control wild-type controls (n = 3). A 32.6% reduction in photoreceptor nuclei was observed in Nr2e3 rd7/rd7 mice, while Prph2 nmf193/? showed a 37.2% reduction. Both Prph2 rds and Nr2e3 rd7/rd7 mutant photoreceptors are known to undergo apoptosis (Chang et al. 1993; Haider et al. 2006) . TUNEL analysis was used to identify apoptotic neurons in the ONL of 1.5-and 10-month-old Prph2 193/? and Nr2e3 rd7/rd7 mutant mice. Approximately 23 TUNEL-positive neurons per 5-lm retinal section were observed in both mutants, indicating a comparable degeneration at 1.5 months old, while at 10 months an average of 5 TUNEL-positive neurons were observed in the thinned ONL (Fig. 8c-e) .
Similar photoreceptor degeneration observed in
Reduced levels of Prph2 are sufficient for photoreceptor loss; therefore, to examine the possibility that Prph2 is involved in the photoreceptor degeneration observed in Nr2e3 rd7/rd7 mice, the levels of Prph2 were measured at the mRNA and protein levels in Nr2e3 rd7/rd7 mutants relative to wild-type controls. Quantitative RT-PCR revealed a 3.2-fold reduction (p = 0.03) of Prph2 expression in Nr2e3 rd7/rd7 mutants relative to wild-type controls (n = 7) (Fig. 9a) . This reduction is far greater than that seen for expression of other rod genes such as rhodopsin, which is reduced by only 1-1.4-fold in Nr2e3 rd7/rd7 mice (Corbo and Cepko 2005; Haider et al. 2006; Peng et al. 2005) . Examining approximately 30 kb of 5 0 sequence in the Prph2 gene, we identified a single NR2E3 response element site and used chromatin immunoprecipitation to evaluate the ability of NR2E3 to bind this site in vivo. These data demonstrate that Prph2 gene expression is directly regulated by NR2E3 (Fig. 9b, c) . In addition, consistent with the message level, immunohistochemical analysis showed reduced expression of PRPH2 protein in NR2e3 rd7/rd7 retinas compared to normal controls (Fig. 9d, e) .
Discussion
In this report we identified a novel mutation in the Prph2 gene that causes photoreceptor degeneration in the nmf193 mouse mutant. The temporal and spatial patterns of degeneration are interesting due to their similarity to those of another mouse mutant, Nr2e3 rd7/rd7 . Nmf193 is inherited in a dominant fashion and linked to chromosome 17. Fine mapping localized the mutation to a region containing Prph2. The similarity between the nmf193 phenotype and that of rds in both the heterozygous and the homozygous state indicated that Prph2 was a strong candidate gene. We identified a splice mutation altering the invariable T in the splice donor. Sequencing RNA confirmed the use of a cryptic splice site and a resulting frameshift. This mutation is a T:A transversion, which is the most common change induced by ENU seen in the mouse (Barbaric et al. 2007 ). This nucleotide change was not detected in the strain of origin. The mutation reduced mRNA levels significantly in the heterozygous mutant mouse, where mutant message is barely detectable, and wild-type message is estimated at slightly less than 50% of normal. This probably reflects an early onset of abnormalities in the retina rather than an adverse effect on expression that the mutant allele has on the wild-type allele. The mutation has a drastic effect on mutants. Hematoxylin and eosin staining shows outer nuclear layers reduced to 5-7 cells thick in the central retina of both mutants (a, b). Scale bar indicates 50 lm. TUNEL staining was used to identify apoptotic nuclei in the outer nuclear layer per 5-lm section in both mutants at 1.5 and 10 months (c-e). Wild-type controls showed negligible TUNEL staining at both time points. A total of 100 lm of sections were counted per mouse the protein, significantly altering the second intradisk loop and deleting the fourth transmembrane region and a known fusion domain (Boesze-Battaglia et al. 2000; Ritter et al. 2004) . The second intradisk loop is essential for the formation of homo-and heterocomplexes with ROM-1 . However, very low levels of mutant message are detected; therefore, this allele would likely result in a loss of function. Prph2 is essential for the development and maintenance of photoreceptor outer segments. It appears that the protein is required for both rods and cones; however, the mutant protein affects the two photoreceptors differently. Electroretinography studies showed that haploinsufficiency of Prph2 has a greater disruptive effect on the rods than it does on cones (Cheng et al. 1997) . Using the cone-enriched Nrl-/-mutant, it was shown that cone outer segments are abnormal in a compound mutant; however, they are present and phototransduction competent, in contrast to rod outer segments (Boesze-Battaglia et al. 2000; Farjo et al. 2007 ). Furthermore, there are differences in degeneration; earlyonset apoptosis is seen in rods but has not been observed in cones.
The nmf193 mutant was generated by ENU mutagenesis, which is a powerful phenotype-driven approach to define gene function relevant to disease pathology. It is noteworthy that many of the novel mutants generated are new alleles of genes that had already been associated with a particular phenotype (Jablonski et al. 2005; Kiernan et al. 2002; Pinto et al. 2005; Sachs et al. 2007 ). This effect could be due to the combination of selection bias, early embryonic lethality, and the large number of knockout and spontaneous mouse mutants that have been generated and identified over the years. In a recent mapping study, nearly half of the genes in a 1-Mb interval on chromosome 6 had already been associated with a phenotype ). Thus, it appears that saturation of the mouse genome with mutations might come sooner rather than later.
We determined that Prph2 is a direct target of the nuclear hormone receptor gene Nr2e3. Mutations in mouse Nr2e3 (Nr2e3 rd7/rd7 ) result in a slow progressive retinal degeneration (Akhmedov et al. 2000; Haider et al. 2006) , while mutations in human Nr2e3 are associated with Enhanced S Cone syndrome and, more recently, autosomal dominant retinitis pigmentosa (Coppieters et al. 2007; Haider et al. 2000; Lam et al. 2007) . While the major phenotype of Nr2e3 rd7/rd7 mice is a superfluous production of blue cone cells, they also exhibit outer-segment defects. Reduced Prph2 message and protein levels were observed in Nr2e3 rd7/rd7 mutant retinas, comparable to the reduction we observed in Prph2 nmf193/? . Since it is well established by the rds mutant that the deficiency of Prph2 is sufficient for photoreceptor degeneration, it is of interest when reduced levels are seen in other mutants. While degenerating photoreceptors in mature Nr2e3 rd7/rd7 retinas may cause some reduction of Prph2 expression, it is more difficult to explain how this Prph2 expression would be altered simply as a secondary effect given that expression of other rod genes was found to be very minimally reduced (Corbo and Cepko 2005; Haider et al. 2006; Peng et al. 2005) . A comparison of the phenotypes of the two mutants revealed that similarities exist between them in the severity and progression of photoreceptor degeneration. It is an intriguing possibility that Prph2 has a role in the degeneration observed in the Nr2e3 rd7/rd7 mutants and in the related human retinal diseases. The decreased levels of Prph2 are either indicative that Nr2e3 is involved in the regulation of Prph2 and may also be an effect of photoreceptor degeneration in the Nr2e3 rd7/rd7 retina. While the data we have shown suggest that Nr2e3 is involved in the regulation of Prph2, gene transfer experiments to overexpress Prph2 in an Nr2e3 rd7/rd7 retina will be required to show that reduction of Prph2 in the Nr2e3 rd7/rd7 retina is an integral part of the degenerative process.
